EVERSANA

Patients

How pharma is tackling new direct-to-patient programmes

At Reuters Pharma USA, executives from AstraZeneca, Gilead, Kyowa Kirin, and EVERSANA discussed the what, why, and how of direct-to-patient models.

Patients

Reuters pharma USA 2025 Faruk Abdullah interview

Direct-to-patient is more than just telehealth – with EVERSA...

Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.

News

EVERSANA joins with Veeva in push to 'pharmatise AI'

EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.

News

Lyfegen partners EVERSANA on pricing, access resource

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.

Sales & Marketing

Industry Insights: A Solution Spotlight – EVERSANA COMPLETE ...

In 2020, commercial leadership at EVERSANA, well versed in the transformation of the contract research organisation (CRO) sector, believed that the often slow-to-pivot pharmaceutical indust

News

ConTIPI starts rollout of pelvic organ prolapse device in US

A non-invasive device that could help millions of women in the US with a condition known as pelvic organ prolapse (POP) has launched in the US.

How pharma is tackling new direct-to-patient programmes

Direct-to-patient is more than just telehealth – with EVERSA...

EVERSANA joins with Veeva in push to 'pharmatise AI'

Lyfegen partners EVERSANA on pricing, access resource

Industry Insights: A Solution Spotlight – EVERSANA COMPLETE ...

ConTIPI starts rollout of pelvic organ prolapse device in US

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

EVERSANA

Editor's Picks